Advertisement

Index by author

May 01, 2014; Volume 349,Issue 2

  1. Felsing, Daniel

    1. A Novel Aminotetralin-Type Serotonin (5-HT) 2C Receptor-Specific Agonist and 5-HT2A Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses
      Clinton E. Canal, Drake Morgan, Daniel Felsing, Krishnakanth Kondabolu, Neil E. Rowland, Kimberly L. Robertson, Rajeev Sakhuja and Raymond G. Booth
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 310-318; DOI: https://doi.org/10.1124/jpet.113.212373

  2. Ferris, Mark J.

    1. Intermittent Cocaine Self-Administration Produces Sensitization of Stimulant Effects at the Dopamine Transporter
      Erin S. Calipari, Mark J. Ferris, Cody A. Siciliano, Benjamin A. Zimmer and Sara R. Jones
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 192-198; DOI: https://doi.org/10.1124/jpet.114.212993

  3. Flik, G.

    1. Arginase Inhibition Prevents Inflammation and Remodeling in a Guinea Pig Model of Chronic Obstructive Pulmonary Disease
      T. Pera, A. B. Zuidhof, M. Smit, M. H. Menzen, T. Klein, G. Flik, J. Zaagsma, H. Meurs and H. Maarsingh
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 229-238; DOI: https://doi.org/10.1124/jpet.113.210138

  4. Fujiki, Hiroyuki

    1. Tolvaptan Delays the Onset of End-Stage Renal Disease in a Polycystic Kidney Disease Model by Suppressing Increases in Kidney Volume and Renal Injury
      Miki Aihara, Hiroyuki Fujiki, Hiroshi Mizuguchi, Katsuji Hattori, Koji Ohmoto, Makoto Ishikawa, Keisuke Nagano and Yoshitaka Yamamura
      Journal of Pharmacology and Experimental Therapeutics May 2014, 349 (2) 258-267; DOI: https://doi.org/10.1124/jpet.114.213256
Back to top

In this issue

Advertisement